Page 88 - IngresoDr.MtzLanao

McAllister M, Zane P (2017). Industry-Academic Collaboration in Oral Biopharmaceutics: The
European IMI OrBiTo Project. Mol Pharm., 14(12): 4129-4131.

Mcculloch, WS & Pitts WA (1943). A logical calculus of the ideas immanent in nervous activity.
Bull. Math. Biophys., 5: 115–133.

Michaelis L, Menten ML (1913). Die kinetic der Invertinwirking. Biochem Z., 49: 333-369.

Mikulecky, DC (1990). Modeling Intestinal absorption and other nutrition-related processes
using PSPICE and STELLA. J. Pediat Gastroenterol Nutr., 11: 7–20.

Millán CG, Castañeda AZ, López FG, Marinero ML, Lanao JM, Arévalo M (2005). Encapsulation
and in vitro evaluation of amikacin-loaded erythrocytes. Drug Deliv., 12(6): 409-416.

Millán CG, Marinero ML, Castañeda AZ, Lanao JM (2004). Drug, enzyme and peptide delivery
using erythrocytes as carriers. J Control Release., 95(1): 27-49.

Mirza MA, Iqbal Z (2018). 3D Printing in Pharmaceuticals: Regulatory Perspective Curr Pharm
Des., 24(42): 5081-5083.

Mitragotri S, Burke PA, Langer R (2014). Overcoming the challenges in administering
biopharmaceuticals: formulation and delivery strategies. Nat Rev Drug Discov., 13(9): 655-672.

Mizuno T, Dong M, Taylor ZL, Ramsey LB, Vinks AA (2020). Clinical implementation of
pharmacogenetics and model-informed precision dosing to improve patient care. Br J Clin
Pharmacol. doi: 10.1111/bcp.14426

Mohammed A, Elshaer A, Sareh P, Elsayed M, Hassanin H (2020).
Additive Manufacturing Technologies for Drug Delivery Applications. Int J Pharm., 580: 119245.

Morrison AB, Champam DG, Campbell JA (1959). Further studies of tablets and the urinary
excretion rates of riboflavin J Am Pharm Assoc Sci Ed., 48: 634-637.

Morrison AB, Campbell JA (1960). The relationsship between physiological availability of
salicylates and riboflavin and in vivo disintegration time of enteric-coated tablets. J Am Pharm
Assoc Sci Ed., 49: 473-478.

Morrison AB, Perusse CB, Campbell JA (1962). Relationship between in vitro desintegration time
and in vivo release of vitamins from a triple doses paced –release preparation. J Pharm Sci., 51:
623-626.

Morrison AB, Campbell JA (1965). Tablet disintegration and physiological availability of drugs. J
Pharm Sci., 54: 1-8.

Neborachko M, Pkhakadze A, Vlasenko I (2019). Current trends of digital solutions for diabetes
management. Diabetes Metab Syndr. 13(5): 2997-3003.

Nelson E (1961). Kinetic of drug absorption, distribution, metabolism and excretion. J Pharm Sci.,
50: 181-192.

Nerst W, Brunner E (1904). Theorie der reakstionsgeschwindigkeit in heterogenen systemen. Zit
Phys Chem., 47: 52-55.

86